Study reveals how live bacterial therapy reshapes the vaginal microbiome and identifies predictors of treatment success

A new study from the Kwon Lab at the Ragon Institute, published in Cell Host & Microbe, provides the most detailed picture yet of how a promising bacterial therapy works to prevent recurrent bacterial vaginosis (BV) and why it works better for some women than others.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup